Raphael Pharmaceutical (RAPH) Change in Accured Expenses (2025)

Raphael Pharmaceutical (RAPH) reported Change in Accured Expenses of $31000.0 for Q4 2025, up 1450.0% sequentially from $2000.0 in Q3 2025.

Raphael Pharmaceutical (RAPH) Change in Accured Expenses (2025) Analysis & Trends

Raphael Pharmaceutical (RAPH) has 1 years of Change in Accured Expenses data on file, last reported at $31000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Accured Expenses (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-144.00 Mn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-234.00 Mn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-12.70 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-14.30 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Raphael Pharmaceutical	27.37 Mn	27.33 Mn	-	31,000.00

Download Data